Doctors will soon be looking for adults in the US and Canada who suffer from vitiligo and who may be interested in joining a clinical research study.
This trial represents the fruition of years of scientific research to develop this promising drug candidate. The aim of the trial is to evaluate the efficacy and safety of an investigational drug for vitiligo.
You may qualify for this study if you:
- Aged 18-65
- Have generalized vitiligo for 3 months or more
- Have active vitiligo lesions on the face or the body.
If you qualify, enrollment will last for up to 60 weeks, or about one year. As part of the study, you will receive all study-related medication and care at no cost to you. You’ll also have appointments at a study clinic near you during your participation. Teams at the trial locations will constantly monitor your health situation to assess the drug safety and see how you’re responding to study drug.
A spirit of collaboration binds different institutions and researchers that are conducting the trial in multiple centers across the USA and Canada.
This collective effort gives us great encouragement that the scientific community will succeed at developing an effective drug for vitiligo. Results of the trial are expected in early 2021.
If you’re interested and would like to learn more please visit the website of the Pfizer Clinical Trials Contact Center
- Is there a traditional medicine to treat vitiligo?
Traditional medicines may be helpful in chronic, metabolic, and stress-related conditions early in the disease manifestation, before extensive tissue and organ damage has occurr...
- What tests should be done?
A well-trained dermatologist should be able to diagnose vitiligo and distinguish it from contact leukoderma or more than twenty other conditions with similar skin appearance bas...
- Polypodium leucotomos as an adjunct treatment for vitiligo?
Extracts of the tropical fern Polypodium leucotomos appear to have beneficial properties for the vitiligious skin. Polypodium leucotomos (also classified as Polypodium aureum) a...
Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.Copyright (C) Bodolóczki Júlia
By taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.